CHICAGO--(BUSINESS WIRE)--Ultrasound contrast agents show promise for detecting and evaluating uterine disorders and prostate cancers, scientists reported today at the annual Advances in Contrast ...

CHICAGO--(BUSINESS WIRE)--Doctors are finding that contrast enhanced ultrasound (CEUS) is so effective in imaging kidney masses in patients with polycystic kidney disease that “they go right to CEUS ...

Contrast enhanced ultrasound (CEUS) often streamlines hospital workflows while providing safe, accurate and cost-effective diagnostic imaging, according to responses to a survey described today at a ...

Contrast-enhanced ultrasound (CEUS) has increasingly emerged as a pivotal imaging modality in the diagnosis and management of abdominal trauma. By utilising microbubble contrast agents, CEUS enhances ...

Contrast-enhanced ultrasound (CEUS) has emerged as a vital imaging tool in the detection, characterisation and prognostic evaluation of breast cancer. By utilising microbubble contrast agents to ...

One of the reasons cardiovascular disease kills 610,000 Americans each year is that it’s hard to see it coming before it’s too late. By the time someone is experiencing chest pain, irreversible damage ...

Supplementary contrast imaging detected more breast cancers than automated whole-breast ultrasound in women with dense breasts. The invasive tumor size found by abbreviated MRI and contrast-enhanced ...

A new contrast agent could allow real-time monitoring of pH changes in the body using an ultrasound scanner (ACS Sens. 2020, DOI: 10.1021/acssensors.0c00245). This expansion of the use of ultrasound ...

The International Contrast Ultrasound Society supports the label change of GE Healthcare’s ultrasound contrast agent Optison, according to a news release. Optison is used in contrast-enhanced ...

Announcing a new article publication for BIO Integration journal. Hepatic perivascular epithelioid cell tumor (PEComa) is a rare tumor with malignant potential that is frequently misdiagnosed as ...